ABSTRACT -Predictive biomarkers of testicular toxicity are needed for an efficient development of drugs. The purpose of the present study was to obtain further insight into the toxicity mechanisms of various male reproductive toxicants and to detect genomic biomarkers for rapid screening of testicular toxicity. Four reproductive toxicants, 2,5-hexanedione (Sertoli cells toxicant), ethylene glycol monomethyl ether (EGME; spermatocytes toxicant), cyclophosphamide (spermatogonia toxicant) and sulfasalazine, were orally administered to male rats once. Six hours after the single dosing, gene expression in the testes was monitored by cDNA microarray and real-time RT-PCR and the testes were histopathologically examined. No histopathological abnormality was detected except for slight degeneration of spermatocytes in the EGME-treated testes. cDNA microarray analysis revealed differential gene expression profiles, and it was possible based on the profiles to characterize the action of the compounds in the testes. Interestingly, 3 spermatogenesis-related genes -heat shock protein 70-2, insulin growth factor binding protein 3 and glutathione S transferase pi -were affected by all the compounds. The above changes of gene expression were detectable within a short period after the dosing prior to the appearance of obvious pathological changes. These data suggest that cDNA microarray is a useful technique for evaluation of primary testicular toxicity. Furthermore, we propose the above 3 spermatogenesis-related genes as potential biomarkers of testicular toxicity.
INTRODUCTION
It takes huge costs and time to develop a new drug. During drug development, an enormous number of candidate compounds are abandoned halfway because of unwanted effects including hepatic, renal, cardiac and testicular toxicity. Therefore, new tools are needed as alternatives to classical toxicological tests for rapid screening. Recently, the "omics" technologies such as toxicogenomics, proteomics and metabonomics have been developed for rapid screening of toxicity, and especially toxicogenomics technology is well developed. In the field of liver and kidney toxicology, toxicogenomics technologies, such as microarray and polymerase chain reaction assay, have already been used in many research studies, including in vitro as well as in vivo studies, and toxicity-related gene markers and expression profiles have been reported (Boess et al., 2003; de Longueville et al., 2003; Lühe et al., 2003; Amin et al., 2004; Thompson et al., 2004) . On the other hand, there have been only a few toxicogenomic investigations in the field of testicular toxicology, although testicular toxicity is one of the important parameters to be considered for drug development.
The purpose of the present study was to obtain further insight into the toxicity mechanisms of various male reproductive toxicants and to detect genomic biomarkers for rapid screening of testicular toxicity following the toxicogenomic approach. Four toxicants were used in this study; 2,5-hexanedione (2,5-HD), ethylene glycol monomethyl ether (EGME), cyclophosphamide (CP) and sulfasalazine (SASP). 2,5-HD is a major metabolite found in the urine of humans exposed to n-hexane (Perbellini et al., 1980) and the first signs of injury in rats are altered Sertoli cells (Boekelheide et al., 2003) . EGME is an organic solvent used in paints and printing inks. From the findings of animal studies, it is known that exposure to this compound leads to testicular atrophy and impaired fertility (Chapin et al., 1984 (Chapin et al., , 1985 , and the target cells seem to be primary spermatocytes in the dividing stage and early and late pachytene stages (Chapin et al., 1984) . CP is an anti-cancer drug and treatment with this drug leads to a decrease of spermatogonia in rats (Matsui et al., 1995) . SASP is a drug for rheumatoid arthritis, acute attacks of ulcerative colitis and Crohn's disease (Svartz, 1942; Baron et al., 1962; Summers et al., 1979) and it is known to cause, as a side effect, male infertility in SASP-treated patients (Levi et al., 1979; Toth, 1979) . Also, SASP is known to affect fertility and sperm motility in rats (Horimoto et al., 2000) . In the present study, male rats were treated with a single dose of each of the above 4 compounds, which have different mechanisms of testicular toxicity, and their effects on testicular gene expression were investigated using cDNA microarray and real-time RT-PCR analysis 6 hr after the dosings. Furthermore, reproductive organs were weighed and testes were pathologically examined.
MATERIALS AND METHODS

Animals and treatment
Twelve-week-old Crj:CD(SD)IGS male rats (n=35) were purchased from Charles River Japan, Inc. (Hino, Shiga, Japan). The animals were acclimated to our laboratory for 7 days prior to treatment and then randomly assigned to a control group and low-and high-dose groups of 2,5-HD, EGME, CP and SASP, according to their body weight. The four compounds were purchased from Sigma (St. Louis. MO). The animals were housed in individual cages and maintained under controlled conditions of light (12-hr light/dark cycle) and temperature (23 to 25°C) and allowed to eat pelleted feed and drink municipal drinking water ad libitum.
The rats were administered the compounds once by oral gavage at a dose of 60 and 1000 mg/kg for 2,5-HD, 50 and 2000 mg/kg for EGME and SASP, and 5 and 200 mg/kg for CP. The dose levels were selected as follows: the high dose was set as the toxicological level and the low dose as non-toxicological level. The dose of 2,5-HD was set based on the finding in male rats that administration of more than 700 mg/kg of 2,5-HD as a single dose suppressed sperm motion (Isobe et al., 1998) . In the case of EGME, the dose was set based on the absence of histopathological findings in the testes after a single dose of 50 mg/kg and the degeneration of spermatocytes observed after a single dose of 500 mg/ kg (Chapin et al., 1985) . In the case of CP, the dose was set based on the absence of morphological lesions for 2-weeks after treatment with 5 mg/kg (Watanabe et al., 2000) and a decrease in spermatogenical cells observed after a single dose of 100 mg/kg (Matsui et al., 1995) . In the case of SASP, the dose level was set based on the decreased sperm motion and fertility noted after treatment with a daily dose of 600 mg/kg for 4 weeks (Horimoto et al., 2000) . The control animals were administered distilled water.
All animals were euthanized 6 hr after the dosing. The testes and epididymides were removed and weighed. The left testis was prefixed in 4% neutral buffered paraformaldehyde for pathological examination. The right testis was frozen and stored in liquid nitrogen until use for gene expression analysis. Experiments were designed to minimize the number of animals and the study protocol was in agreement with the Institute of Animal Care & Use Committee of Pfizer Inc.
RNA extraction
Total RNA was extracted from each of the frozen testes using TRIZOL Reagent (Invitrogen Corp., Carlsbad, CA) according to the manufacturer's procedure and poly(A) + RNA was purified from total RNA using Oligotex TM -dT30 <Super> mRNA Purification kit (TaKaRa, Tokyo, Japan). The quality of poly(A) + RNA was checked using Agilent 2100 Bioanalyzer (Agilent Technologies, Tokyo, Japan). Samples from the testes of 5 rats from each group were pooled for analysis using cDNA microarrays and real-time RT-PCR (Adachi et al., 2002) . Vol. 30 No. 3 Microarray analysis of mRNA expression in the testes
Microarray analysis was performed in the 2,5-HD, EGME, CP and SASP-treated high-dose groups. Approximately 3 µg of poly(A) + RNA from each group was converted individually to cyanine 5-dUTP (Perkin Elmer Lifescience, Kanagawa, Japan) labeled cDNA using SuperScript TM II RNase H − reverse transcriptase (Invitrogen Corp.) and oligo (dT) 12-18 primer (Invitrogen Corp.). The labeled cDNA was hybridized to the ED array version 2 (Asahi Techno Glass, Co. Ltd., Chiba, Japan) overnight at 50°C. The ED array version 2 carries a total of 5978 probes consisting of a duplicate of approximately 2000 rat and 900 mouse genes. Two ED arrays were used for each group, 4 measurements in total for each gene. The glass arrays were washed once in 2× SSC/0.03% SDS for 15 min, once in 0.2× SSC for 5 min, once in 0.05× SSC for 5 min and finally in ethanol, and then were dried up. The microarrays were scanned using a fluorescence laserscanning device, ScanArray (GSI Lumonics, Tokyo). The fluorescence intensity of the genes was quantified using microarray analysis software, QuantArray version 2.1 (GSI Lumonics). The data was normalized across arrays using all intensity values of all features on each array. The change in gene expression was determined using functional distinction analysis of Spotfire version 7.2 (Spotfire, Tokyo).
Confirmation of mRNA expression in the testes by real-time RT-PCR
Expression of genes selected by the microarray analysis was quantified by real-time RT-PCR using an ABI Prism 7000 Sequence Detection System (Applied Biosystems, Foster City, CA). Total RNA from each group was reverse-transcribed using SuperScript II reverse transcriptase (Invitrogen Corp.) and oligo-dT. The expressions of the following 3 genes eas measured: insulin growth factor binding protein 3 (IGFBP-3; NM_012588), heat shock protein 70-2 (HSP70-2; Walter et al., 1994) , glutathione S transferase pi (GSTpi; NM_012577). The rat-specific primers for the above genes were designed using Primer Express software (Applied Biosystems). The primer sequences are shown in Table 1 . A standard curve was created using appropriate dilutions of a sample of cDNA synthesized from testicular total RNA of a control animal. The samples were quantified using the values calculated from standard curves for each gene. The SYBR Green PCR Master mix (Applied Biosystems) was used for real-time RT-PCR analysis. Quantification of 18s ribosomal RNA gene expression was performed using ribosomal RNA control (18sRNA) and TaqMan Universal PCR Master mix for internal controls. Real-time RT-PCR analysis was performed in triplicate for each group. The value of each sample was normalized using the value of 18s ribosomal RNA, and then the relative value of expression in each treated group was calculated by setting the control at 1.
Pathological examination
The fixed testes were trimmed, dehydrated, embedded in paraffin, sectioned, mounted on glass slides, stained with hematoxylin and eosin, and examined by light microscopy.
Statistical analysis
Data were statistically analyzed using Dunnet's ttest (Dunnet, 1964) . Probability less than 5% was considered statistically significant.
RESULTS
Effect of 2,5-HD, EGME, CP and SASP on the weight of reproductive organs
There were no differences in the weight of testes and epididymides between the control and each treatment group (Table 2) . 
Pathological changes in the testes
Partial and slight degeneration of spermatocytes was observed in the EGME high-dose group (Photo 1). On the other hand, there were no remarkable findings in the EGME low-dose group, 2,5-HD, CP and SASP treatment groups (Data not shown).
cDNA microarray analysis of gene expression in the testes
As a result of cDNA microarray analysis, 9, 10, 9 and 5 spermatogenesis-related genes were up-regulated and 8, 5, 6, and 5 genes were down-regulated in the 2,5-HD, EGME, CP and SASP high-dose group, respectively (Table 3 ). The number of affected genes in the SASP high-dose group was lower than that in the other high-dose groups. The number of DNA repairrelated genes was the highest in the CP high-dose group (Table 3 ). Regarding spermatogenesis-related genes affected by the testicular toxicants, these are listed in Table 4 . Three genes, namely IGFBP-3, HSP70-2 and GST-pi, were affected in all the highdose groups.
Real-time RT-PCR analysis of mRNA expression in the testes
The expression of IGFBP-3 was significantly decreased in the 2,5-HD low-and high-dose groups when compared to the control, and the decrease was dose-related (Fig. 1) . In the EGME groups, a significant increase of IGFBP-3 expression was observed in the high-dose group and the expression tended to increase in the low-dose group (Fig. 1 ). In the CP groups, the expression was decreased in the high-dose group, but no change was found in the low-dose group (Fig. 1 ). In the SASP groups, a significant increase in the low-dose group and a significant decrease in the high-dose group were observed (Fig. 1) .
As to the expression of HSP70-2, a significant increase was observed in the 2,5-HD and EGME highdose groups when compared to the control (Fig. 2) . In the CP and SASP high-dose groups, a significant decrease was noted (Fig. 2) . On the other hand, the expression of the gene was not altered in any of the low-dose groups (Fig. 2) .
Regarding the expression of GST-pi, a statistically significant decrease was observed in the 2,5-HD high-dose group (Fig. 3) . In the EGME and CP highdose groups, the expression was increased (Fig. 3) . In the SASP low-and high-dose groups, GST-pi expression was significantly decreased (Fig. 3) .
DISCUSSION
In the present study, treatment with low doses of 2,5-HD, EGME, CP and SASP resulted in the absence of clinical signs, no changes in reproductive organ weight and no pathological findings in the testes. Thus these compounds are considered to have no adverse effect on the testes at these low-dose levels. On the other hand, a treatment-related pathological finding was obtained in the EGME high-dose group 6 hours after treatment. This effect of EGME has been well documented (Wang and Chapin, 2000) . However, in the remaining groups, namely 2,5-HD, CP and SASP high-dose groups, there were no remarkable findings. An increase in the number of sperm with abnormal motion has been noted in rats treated once with 2,5-HD at more than 700 mg/kg (Isobe et al., 1998) . Morphological changes can be detected from Day 7 even after a single administration of CP at 100 mg/kg (Matsui et al., 1995) . Therefore, the high-dose level of each compound used in this study is considered the toxicological level. Failure in detection of remarkable changes in the 2,5-HD, CP and SASP high-dose groups in this study might be attributed to the time point of observation; 6 hr after the treatment might be too early for pathological changes to appear. Therefore, to investigate the molecular basis and predictive biomarkers of the toxicity of these compounds, cDNA microarray analysis was performed in the high-dose groups, and then the expression of selected genes was quantified in the lowdose as well as high-dose groups.
The cDNA microarray analysis revealed that many genes were affected by the 4 compounds in the testis 6 hr after the treatments. A relatively large number of spermatogenesis-related genes were among the affected genes. Of them, IGFBP-3, HSP70-2 and GSTpi were affected by all the compounds. Therefore we selected these genes for quantification of their expression by real-time RT-PCR analysis. The results of quantification in the high-dose groups were the same as those of microarray analysis. This fact supports the validity of the present microarray data.
Furthermore, we quantified the expression of these genes in the low-dose groups. In most cases, treatments with low doses of the tested toxicants did not affect the expression of these three genes. In two cases, however, IGFBP-3 expression in the 2,5-HD groups and GST-pi expression in the SASP groups, the expression levels in the low-dose groups were signifi- cantly lower than the control values but higher than those in the high-dose groups. These data might reflect a dose-dependence of gene expression changes. From the assessment of safety standpoints, all low-doses are regarded as the no-adverse-effect dose level. Thus, these findings indicted that in the low-dose groups gene expression decreased before the changes of safety parameters in vivo became evident. On the other hand, IGFBP-3 expression was also altered by SASP at the low-dose level, but the effect of SASP was opposite to that observed in the high-dose group. The reason for their reciprocal expression changes induced by SASP is unknown. 2,5-HD is known to be a Sertoli cells toxicant (Boekelheide et al., 2003) . It was found in the present cDNA microarray analysis that the gene expression of Sertoli-germ cells adhesion molecules such as cadherin (Johnson et al., 2000) , fibronectin (Schaller et al., 1993) , and integrin (Siu et al., 2003) was decreased in the 2,5-HD high-dose group. Furthermore, the genes that are expressed in Sertoli cells such as IGFBP-3 (Smith et al., 1990) , ferritin (Carreau, 1996) , epidermal growth factor receptor (Suarez-Quian et al., 1994) and GST-pi (Mukherjee et al., 1999) were altered. Expression changes of these genes might underlie the toxicity of 2,5-HD observed in Sertoli cells. Additionally, thiol-specific antioxidant protein and HSP70-2 that are expressed in germ cells were affected by 2,5-HD. The testes of rats treated with 2,5-HD, histopathological alterations in Sertoli cells were observed as the first morphological changes (Chapin et al., 1983) . It is well known that 2,5-HD targets Sertoli cells, resulting in germ cell apoptosis and testicular atrophy (Boekelheide et al., 2003) , but it is uncertain whether 2,5-HD directly attacks germ cells. Based on previous studies, the expression change of genes found in germ cells is considered a secondary effect of dysfunction of Sertoli cells, although the possibility that it was a direct effect of 2,5-HD on germ cells cannot be ruled out. From the above findings, it is suggested that there is a specific toxicological pathway, namely dysfunction of Sertoli cells and subsequent damage to germ cells as a second- ary effect, at least in testicular toxicity induced by 2,5-HD.
As for EGME treatment, the main target cells are known to be primary spermatocytes in the dividing stage and those in the early and late pachytene stages (Chapin et al., 1984) , and neighboring cells such as Sertoli cells are also known to be affected (Creasy et al., 1986) . In the present microarray analysis, the expression of glutathione S-transferase Yb, pi and glutathione synthetase was increased. These molecules are known to protect germ cells from electrophilic and oxidative attack (Bauche et al., 1994) . Excessive oxidative stress is known to affect the spermatogenic process (Kaurm and Bansal, 2004) . From these findings, it is considered that excessive oxidative stress, as indicated by up-regulation of glutathione S-transferase Yb, pi and glutathione synthetase, affected spermatogenesis in the EGME high-dose group. Furthermore, the expression of interleukin-1 receptor also increased in the EGME high-dose group. This finding indicates that EGME increases the production of interleukin-1 (IL-1), which is known as a testicular paracrine factor (Wang et al., 1998; Huleihel and Lunenfeld, 2004) . The increase in IL-1 expression is known to induce upregulation of IGFBP-3 (Wang et al., 1995) . IGFBP-3 was found to be up-regulated in the EGME high-dose group by cDNA microarray and real-time RT-PCR. IGFBP-3 inhibits insulin-like growth factor-I (IGF-1) activity in the testes (Rappaport and Smith, 1995) and IGF-1 has a stimulatory effect on the last step of spermatogenesis (Ito et al., 1994) . Therefore, it is considered that EGME affects the expression of the paracrine factor and IGFBP-3, and finally inhibits the stimulatory function of IGF-1 in spermatogenesis. Thus, the above-mentioned data suggest that EGME affects spermatogenesis in the early phase at least via two toxicological pathways, namely by excessive oxidative stress and by altering the testicular paracrine system.
In the CP high-dose group, a lot of DNA repairrelated genes were found to be affected by cDNA microarray analysis. Similar results were obtained in a previous study in rats treated once with CP at 100 mg/ kg (Aguilar-Mahecha et al., 2001) . It is considered that this effect is due to its anti-cancer drug behavior such as DNA damage. Regarding spermatogenesis-related genes, CP affected the expression of Sertoli cellsrelated genes (GST-pi, amphiphysin and IGFBP-3), germ cells-related genes (HSP70-2, hypoxanthine phosphoribosyl transferase and tubulin) and Sertoligerm cells adhesion-related genes (fibronectin). Thus, there was no specificity regarding the spermatogenesis-related genes affected by CP. From the above findings, it was revealed that a lot of DNA repair-related genes were affected as a toxicological pathway of CP treatment.
The target cell of SASP in the testes has not been clearly identified. In our previous study, no obvious change was found in the expression of spermatogenesis-related genes in rats treated with SASP for 28 days at a 600 mg/kg dose level (Fukushima et al., 2005) , suggesting that it was difficult to detect testicular toxicity induced by SASP in rats. In the present study, however, some spermatogenesis-related genes were affected, although the number of affected genes was the lowest as compared to the other compounds highdose groups. This difference in gene expression changes between the present and previous studies might occur because the dose of SASP employed in this study was extremely high. As with the other compounds, IGFBP-3, HSP70-2 and GST-pi were affected by the high dose of SASP. But, in the case of SASP treatment, no characteristic toxicological pathway was found.
Based on gene expression profiles determined by cDNA microarray analysis, it was possible to characterize the action of the compounds on the testes prior to the appearance of morphological and/or functional abnormalities by focusing on the location of expression and biological function of the affected genes. Although the characterization may be rough at present, accumulating knowledge of function and interaction of genes will facilitate more precise characterization and understanding of toxicity mechanisms. Thus, cDNA microarray analysis is a useful technique to evaluate testicular toxicity in the early phase of drug development.
In the present study, we focused on 3 genes, IGFBP-3, HSP70-2 and GST-pi, because these genes were affected by all the compounds examined. As mentioned above, IGFBP-3 works in the testicular paracrine system. HSP70-2 is a molecular chaperon for meiosis in spermatogenesis and knockout mice lacking this gene are infertile (Eddy, 1999) . GST-pi is contained in seminiferous tubular fluid (Aravinda et al., 1995) , and this fluid provides the microenvironment necessary for spermatogenesis (Mukherjee, et al., 1999) . Therefore, alterations of the expression of these molecules may lead to anomalous spermatogenesis. Moreover, it is worthwhile to note that the expression changes of these genes were detectable within a short period after dosing. From these findings, we propose IGFBP-3, HSP70-2 and GST-pi as potential predictive biomarkers of testicular toxicity. However, the response patterns of these genes to the tested compounds were different. Further studies are necessary to link the patterns of expression changes with mechanism-based characteristics of toxicity.
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